Publications by authors named "Brennan D Johnson"

The flavin adenine dinucleotide containing Endoplasmic Reticulum Oxidoreductase-1 α (ERO1α) catalyzes the formation of disulfide bond formation of secretory and transmembrane proteins and contributes towards proper protein folding. Recently, increased ERO1α expression has been shown to contribute to increased tumor growth and metastasis in multiple cancer types. In this report we sought to define novel chemical space for targeting ERO1α function.

View Article and Find Full Text PDF

Endoplasmic reticulum oxidoreductin-1 alpha (ERO1α) was originally shown to be an endoplasmic reticulum (ER) resident protein undergoing oxidative cycles in concert with protein disulfide isomerase (PDI) to promote proper protein folding and to maintain homeostasis within the ER. ERO1α belongs to the flavoprotein family containing a flavin adenine dinucleotide utilized in transferring of electrons during oxidation-reduction cycles. This family is used to maintain redox potentials and protein homeostasis within the ER.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple myeloma (MM) cells are highly sensitive to therapies that stress the endoplasmic reticulum (ER), and increased levels of the enzyme Ero1L are linked to worse patient outcomes.
  • Targeting Ero1L with the inhibitor EN-460 showed promising results by reducing cell growth and inducing cell death through increased ER stress, while also inhibiting Ero1L's activity.
  • EN-460 also affected other enzymes, indicating the need for more selective inhibitors, and researchers are exploring derivatives of EN-460 for better understanding and targeting of Ero1L in treatment strategies for MM.
View Article and Find Full Text PDF